JHP Pharmaceuticals Successfully Completes Audits

JHP Pharmaceuticals sterile manufacturing site based in Rochester, MI successfully completed a GMP/Pre-Approval Audit by the FDA. This audit followed two successful GMP audits in 2009 including an audit by the FDA biologics division (CBER) and an audit by the European Medicines Agency (EMEA), which resulted in a continuance of the certificate of GMP compliance for the manufacturing site.

Stuart Hinchen, co-founder and president of JHP, said, “We are extremely pleased with the results of the recent audits of our Rochester, MI sterile injectable manufacturing facility. We understand the importance of compliant quality systems and we work diligently to maintain these systems to the highest global standards.”

Click here to learn more about JHP Pharmaceuticals